Predict COVID-19 Progression with Peptide Biomarker Test
Peptide-based Test for Prognosis of SARSCoV-2 Infection
Tags: IIT Bombay, India, Healthcare & Lifesciences
This peptide-based test uses a selected reaction monitoring (SRM) assay to predict the progression of SARS-CoV-2 infection severity in patients. It identifies specific severity biomarkers, providing critical insights beyond standard RT-PCR tests. The test enables hospital management to prioritize care for high-risk patients and supports large-scale screenings. The technology has undergone proof-of-concept validation with patient samples, showing promise for global applications in COVID-19 and other infections like malaria and dengue. Its unique approach fills a significant gap in infection prognosis tools, especially for resource-limited settings.
IP Type or Form Factor: Patent Pending; Process & Method; Platform
TRL: 4 - minimum viable product built in lab
Industry or Tech Area: Biotechnology; Public Health & Universal Healthcare
